Evotec SE (EVO) Liabilities and Shareholders Equity (2019 - 2026)

Evotec SE's (EVO) quarterly Liabilities and Shareholders Equity came in at $1.9 million in Q1 2026, down 6.16% year-on-year from $2.0 million in Q1 2025, and up 96125.58% quarter-over-quarter from $1995.1 in Q4 2025.

Evotec SE (EVO) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Evotec SE has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $1.9 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $1.9 million, down 6.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (down 100.0% YoY), and the FY2025 annual result was $1995.1, down 100.0% from the prior year.
  • Liabilities and Shareholders Equity came in at $1.9 million for Q1 2026 at Evotec SE, up from $1995.1 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2452.3 billion in Q1 2022 to a low of $1995.1 in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $49.2 million (2022), against an average of $776.8 billion.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 109429290.55% in 2022 and tumbled 100.0% in 2025, its largest moves.
  • Evotec SE's Liabilities and Shareholders Equity stood at $55.0 million in 2022, then fell by 21.06% to $43.4 million in 2023, then jumped by 4610.0% to $2.0 billion in 2024, then sank by 100.0% to $1995.1 in 2025, then surged by 96125.58% to $1.9 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $1.9 million (Q1 2026), $1995.1 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 40.04 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.35 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 2.27 Bn
10 Evotec SE 583.10 Mn 582.58 Mn - 1.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.92 Mn
Dec 31, 2025 1,995.11
Sep 30, 2025 2.07 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 2.05 Mn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 2,186.35 Bn
Mar 31, 2024 2,399.39 Bn
Dec 31, 2023 43.39 Mn
Dec 31, 2022 54.97 Mn
Sep 30, 2022 2,281.39 Bn
Mar 31, 2022 2,452.33 Bn
Dec 31, 2021 29.12 Mn
Sep 30, 2021 2.08 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2019 12.69 Mn